4//SEC Filing
ALEXION PHARMACEUTICALS INC 4
Accession 0000899866-16-000361
CIK 0000899866operating
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 5:14 PM ET
Size
10.7 KB
Accession
0000899866-16-000361
Insider Transaction Report
Form 4
NORBY R DOUGLAS
Director
Transactions
- Exercise/Conversion
Common Stock, par value $.0001 per share
2016-09-23$128.81/sh−7,202$927,690→ 11,174 total - Exercise/Conversion
Common Stock, par value $.0001 per share
2016-09-23$130.03/sh−2,800$364,084→ 8,374 total - Exercise/Conversion
Common Stock, par value $.0001 per share
2016-09-23$131.10/sh−3,724$488,216→ 4,650 total - Exercise/Conversion
Common Stock, par value $.0001 per share
2016-09-23$131.97/sh−1,774$234,115→ 2,876 total
Footnotes (5)
- [F1]The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $128.35 - $129.35. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $129.35 - $130.35. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F4]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $130.56 - $131.56. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F5]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $131.66 - $132.66. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Documents
Issuer
ALEXION PHARMACEUTICALS INC
CIK 0000899866
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000899866
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 5:14 PM ET
- Size
- 10.7 KB